Journal
PROGRESS IN PEDIATRIC CARDIOLOGY
Volume 21, Issue 2, Pages 219-225Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.ppedcard.2005.11.010
Keywords
Aortic valves; Tissue engineering; Biological scaffolds; Extracellular matrix
Categories
Ask authors/readers for more resources
Currently available heart valve substitutes fail to emulate the sophisticated functions of the native aortic valve, a factor that contributes to their eventual failure. One possible strategy to generate a valve substitute that reproduces the function of the native valve would be to apply the principals of tissue engineering. A crucial step in this process will be the choice of scaffold, which serves as an initial support on which to seed the cells. Successful scaffold materials should be amenable to modification, have a controlled degradation, be compatible with the cells, lack cytotoxicity and not elicit an immune or inflammatory response. Importantly the ideal scaffold should possess cell attachment and signalling molecules that will promote cell population and function, resulting in remodelling of the scaffold into a tissue construct, which can mimic the function of the native valve, possessing the mechanical strength and integrity to withstand aortic pressures. Such molecules are naturally present in biological scaffolds to varying degrees. This chapter discusses the various biological scaffolds that have been considered and are being studied for use in tissue engineering a heart valve and primarily focuses on the aortic valve. Strategies to optimize the physical parameters of the scaffold and to introduce biological signals into synthetic scaffolds or augment biological scaffolds are also discussed. (C) 2005 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available